107007-99-8 Granisetron hydrochloride 98%

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million.  With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.

Natco family currently consists of around 4500 employees, we are consistently ranked among fastest growing pharmaceutical companies in India.  Natco is well recognized for its innovation in Pharmaceutical R&D. NATCO has successfully developed and launched complex drug delivery product – Liposomal Doxorubicin Injection in the US market, in collaboration with Dr. Reddy’s Laboratories. Teams from both the companies, worked on the product development and approval process for more than 5 years. The product will be launched in other markets across the world in the next 2 years. This successful collaboration for a product targeted for global reach, is a testimony of our ability to work on shared goals and build long lasting relationships based on trust.